MeiraGTx Reports Third Quarter 2025 Financial and Operational Results
(NASDAQ:MGTX), Entered into broad strategic collaboration with Eli Lilly and Company (“Lilly”) in the area of ophthalmology, granting Lilly worldwide exclusive rights to the Company's AAV-AIPL1 program for treatment of one of the most severe inherited retinopathies, Leber congenital amaurosis 4 (LCA4) Released material under the Company's Specials license for a second rare pediatric ophthalmology […]